94 related articles for article (PubMed ID: 29770980)
1. What can we learn from the public's understanding of drug information and safety? A population survey.
Salgueiro E; Gurruchaga C; Jimeno FJ; Martínez-Múgica C; Martín Arias LH; Manso G
Int J Pharm Pract; 2019 Feb; 27(1):96-104. PubMed ID: 29770980
[TBL] [Abstract][Full Text] [Related]
2. Low awareness of adverse drug reaction reporting systems: a consumer survey.
Robertson J; Newby DA
Med J Aust; 2013 Nov; 199(10):684-6. PubMed ID: 24237099
[TBL] [Abstract][Full Text] [Related]
3. Are consumers ready to take part in the Pharmacovigilance System?--a Portuguese preliminary study concerning ADR reporting.
Matos C; van Hunsel F; Joaquim J
Eur J Clin Pharmacol; 2015 Jul; 71(7):883-90. PubMed ID: 26004569
[TBL] [Abstract][Full Text] [Related]
4. Public confidence in ADR identification and their views on ADRreporting: mixed methods study.
Jarernsiripornkul N; Patsuree A; Krska J
Eur J Clin Pharmacol; 2017 Feb; 73(2):223-231. PubMed ID: 27837337
[TBL] [Abstract][Full Text] [Related]
5. Patients' use of information about medicine side effects in relation to experiences of suspected adverse drug reactions: a cross-sectional survey in medical in-patients.
Krska J; Morecroft CW
Drug Saf; 2013 Aug; 36(8):673-80. PubMed ID: 23700262
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
[TBL] [Abstract][Full Text] [Related]
7. The contribution of Ghanaian patients to the reporting of adverse drug reactions: a quantitative and qualitative study.
Jacobs TG; Hilda Ampadu H; Hoekman J; Dodoo ANO; Mantel-Teeuwisse AK
BMC Public Health; 2018 Dec; 18(1):1384. PubMed ID: 30563498
[TBL] [Abstract][Full Text] [Related]
8. Medicine safety: experiences and perceptions of the general public in Liverpool.
Krska J; Jones L; McKinney J; Wilson C
Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1098-103. PubMed ID: 21809408
[TBL] [Abstract][Full Text] [Related]
9. Community pharmacists' attitudes, perceptions, and barriers toward adverse drug reaction reporting in Malaysia: a quantitative insight.
Elkalmi RM; Hassali MA; Ibrahim MI; Jamshed SQ; Al-Lela OQ
J Patient Saf; 2014 Jun; 10(2):81-7. PubMed ID: 24618640
[TBL] [Abstract][Full Text] [Related]
10. Experiences relating to adverse drug reactions in the community: a cross-sectional survey among patients and the general public in Thailand.
Patsuree A; Krska J; Jarernsiripornkul N
Expert Opin Drug Saf; 2016; 15(3):287-95. PubMed ID: 26750422
[TBL] [Abstract][Full Text] [Related]
11. Patients' Perspectives on Adverse Drug Reaction Reporting in a Developing Country: A Case Study from Ghana.
Sabblah GT; Darko DM; Mogtari H; Härmark L; van Puijenbroek E
Drug Saf; 2017 Oct; 40(10):911-921. PubMed ID: 28653291
[TBL] [Abstract][Full Text] [Related]
12. Survey to assess public awareness of patient reporting of adverse drug reactions in Great Britain.
Fortnum H; Lee AJ; Rupnik B; Avery A;
J Clin Pharm Ther; 2012 Apr; 37(2):161-5. PubMed ID: 21592158
[TBL] [Abstract][Full Text] [Related]
13. Knowledge of and attitudes about adverse drug reaction reporting among Rhode Island pharmacists.
Generali JA; Danish MA; Rosenbaum SE
Ann Pharmacother; 1995 Apr; 29(4):365-9. PubMed ID: 7633012
[TBL] [Abstract][Full Text] [Related]
14. Hospital pharmacists' knowledge and opinions regarding adverse drug reaction reporting in Northern China.
Su C; Ji H; Su Y
Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):217-22. PubMed ID: 20033911
[TBL] [Abstract][Full Text] [Related]
15. Adverse drug reaction reporting among health care workers at Mulago National Referral and Teaching hospital in Uganda.
Katusiime B; Semakula D; Lubinga SJ
Afr Health Sci; 2015 Dec; 15(4):1308-17. PubMed ID: 26958036
[TBL] [Abstract][Full Text] [Related]
16. Knowledge of Adverse Drug Reaction Reporting and the Pharmacovigilance of Biological Medicines: A Survey of Healthcare Professionals in Ireland.
O'Callaghan J; Griffin BT; Morris JM; Bermingham M
BioDrugs; 2018 Jun; 32(3):267-280. PubMed ID: 29721705
[TBL] [Abstract][Full Text] [Related]
17. Pharmacists' attitudes toward adverse drug reaction reporting in Hong Kong.
Lee KK; Chan TY; Raymond K; Critchley JA
Ann Pharmacother; 1994 Dec; 28(12):1400-3. PubMed ID: 7696734
[TBL] [Abstract][Full Text] [Related]
18. Knowledge, Practice and Attitudes Toward Pharmacovigilance and Adverse Drug Reactions Reporting Process Among Health Care Providers in Dammam, Saudi Arabia.
Ali MD; Hassan YA; Ahmad A; Alaqel O; Al-Harbi H; Al-Suhaimi NM
Curr Drug Saf; 2018; 13(1):21-25. PubMed ID: 29256354
[TBL] [Abstract][Full Text] [Related]
19. The lack of knowledge about the voluntary reporting system of adverse drug reactions as a major cause of underreporting: direct survey among health professionals.
Pérez García M; Figueras A
Pharmacoepidemiol Drug Saf; 2011 Dec; 20(12):1295-302. PubMed ID: 21793098
[TBL] [Abstract][Full Text] [Related]
20. Knowledge of Adverse Drug Reaction Reporting Among Healthcare Professionals in Bhutan: A Cross-Sectional Survey.
Dorji C; Tragulpiankit P; Riewpaiboon A; Tobgay T
Drug Saf; 2016 Dec; 39(12):1239-1250. PubMed ID: 27743333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
